Association between various dosage forms of semaglutide and ocular adverse events in a real-world setting

Related articles

1. The real-world safety of Pexidartinib: a pharmacovigilance analysis based on the FDA adverse event reporting system

   This article has 7 authors:

   1. Dan Chen
   2. Xia-wen Yang
   3. Jing Fu
   4. Deng-zheng Zhang
   5. Guo-Qing Chen
   6. Wei Cai
   7. Wen-long Xie

2. Real-world study of adverse events associated with selumetinib based on the VigiAccess and FAERS databases

   This article has 6 authors:

   1. Feilong Tan
   2. Wenjie Yin
   3. Zhongjuan Wang
   4. Lina You
   5. Yanhua Li
   6. Hongying Xia

3. Cardiotoxicity associated with different 5-HT3RAs: pharmacovigilance analysis of the FDA Adverse Event Reporting System database study and a pharmacokinetic study

   This article has 8 authors:

   1. Yijun Cai
   2. Shaohong Luo
   3. Shen Lin
   4. Xiaoting Huang
   5. Xiangzhen Wang
   6. Lijing Yang
   7. Xiongwei Xu
   8. Xiuhua Weng